• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年多病患者的静脉血栓栓塞症预防。

Prophylaxis of venous thromboembolism in elderly patients with multimorbidity.

机构信息

Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.

出版信息

Intern Emerg Med. 2013 Sep;8(6):509-20. doi: 10.1007/s11739-013-0944-8. Epub 2013 May 8.

DOI:10.1007/s11739-013-0944-8
PMID:23653407
Abstract

Pharmacological thromboprophylaxis (TP) is known to reduce venous thromboembolism (VTE) in medical inpatients, but the criteria for risk-driven prescription, safety and impact on mortality are still debated. We analyze data on elderly patients with multimorbidities admitted in the year 2010 to the Italian internal medicine wards participating in the REPOSI registry to investigate the rate of TP during the hospital stay, and analyze the factors that are related to its prescription. Multivariate logistic regression, area under the ROC curve and CART analysis were performed to look for independent predictors of TP prescription. Association between TP and VTE, bleeding and death in hospital and during the 3-month post-discharge follow-up were explored by logistic regression and propensity score analysis. Among the 1,380 patients enrolled, 171 (15.2 %) were on TP during the hospital stay (162 on low molecular weight heparins, 9 on fondaparinux). The disability Barthel index was the main independent predictor of TP prescription. Rate of fatal and non-fatal VTE and bleeding during and after hospitalization did not differ between TP and non-TP patients. In-hospital and post-discharge mortality was significantly higher in patients on TP, that however was not an independent predictor of mortality. Among elderly medical patients there was a relatively low rate of TP, that was more frequently prescribed to patients with a higher degree of disability and who had an overall higher mortality.

摘要

药物性血栓预防(TP)被证实可以降低住院患者的静脉血栓栓塞症(VTE)风险,但基于风险驱动的处方、安全性和对死亡率的影响仍存在争议。我们分析了 2010 年意大利内科病房参加 REPOSI 注册研究的合并多种疾病的老年患者的数据,以调查住院期间 TP 的使用率,并分析与其处方相关的因素。采用多变量逻辑回归、ROC 曲线下面积和 CART 分析寻找 TP 处方的独立预测因素。通过逻辑回归和倾向评分分析探讨 TP 与住院期间和出院后 3 个月内 VTE、出血和死亡之间的关系。在纳入的 1380 名患者中,171 名(15.2%)在住院期间接受了 TP(162 名接受低分子肝素,9 名接受磺达肝素)。残疾 Barthel 指数是 TP 处方的主要独立预测因素。住院期间和出院后致命和非致命 VTE 和出血的发生率在 TP 组和非 TP 组之间没有差异。TP 组的住院和出院后死亡率显著更高,但并非死亡率的独立预测因素。在老年内科患者中,TP 的使用率相对较低,更频繁地用于残疾程度较高且总体死亡率较高的患者。

相似文献

1
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity.老年多病患者的静脉血栓栓塞症预防。
Intern Emerg Med. 2013 Sep;8(6):509-20. doi: 10.1007/s11739-013-0944-8. Epub 2013 May 8.
2
Prescription appropriateness of anticoagulant drugs for prophylaxis of venous thromboembolism in hospitalized multimorbid older patients.住院多病共存老年患者预防性使用抗凝药物预防静脉血栓栓塞的处方适宜性
Intern Emerg Med. 2023 Jan;18(1):97-104. doi: 10.1007/s11739-022-03121-7. Epub 2022 Oct 14.
3
Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.对有静脉血栓栓塞风险的住院内科和外科患者实施血栓预防的干预措施。
Cochrane Database Syst Rev. 2013 Jul 16(7):CD008201. doi: 10.1002/14651858.CD008201.pub2.
4
Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.在接受大型骨科手术的连续患者中,使用磺达肝素或低分子肝素进行静脉血栓栓塞预防的疗效和安全性 - 来自 ORTHO-TEP 登记处的结果。
Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.
5
Hospital Acquired Thrombosis (HAT) Prevention in an Acute Hospital; A Single Centre Cross-Sectional Study.急性医院中院内血栓形成(HAT)的预防;一项单中心横断面研究。
Ir Med J. 2017 Apr 10;110(4):547.
6
Improving thromboprophylaxis in the medical inpatients: The role of the resident in an academic hospital.改善住院内科患者的血栓预防:住院医师在学术型医院中的作用。
Phlebology. 2023 Mar;38(2):91-95. doi: 10.1177/02683555221147472. Epub 2022 Dec 20.
7
Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients. A retrospective multicenter study.急性病住院内科患者的静脉血栓栓塞预防。一项回顾性多中心研究。
Eur J Intern Med. 2014 Oct;25(8):717-23. doi: 10.1016/j.ejim.2014.07.005. Epub 2014 Aug 1.
8
Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study.急性内科疾病住院与静脉血栓栓塞症风险的关联:老年患者的抗栓预防效果较低?来自 EDITH 病例对照研究的结果。
Eur J Intern Med. 2017 Oct;44:39-43. doi: 10.1016/j.ejim.2017.05.029. Epub 2017 Jun 22.
9
Compliance with current VTE prophylaxis guidelines and risk factors linked to complications of VTE prophylaxis in medical inpatients: a prospective cohort study in a Spanish internal medicine department.内科住院患者对当前静脉血栓栓塞症(VTE)预防指南的依从性以及与VTE预防并发症相关的危险因素:西班牙一个内科科室的前瞻性队列研究
BMJ Open. 2018 May 14;8(5):e021288. doi: 10.1136/bmjopen-2017-021288.
10
Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.医学疾病患者人群中的血栓预防模式、风险因素和护理结果。
Thromb Res. 2013 Nov;132(5):520-6. doi: 10.1016/j.thromres.2013.08.013. Epub 2013 Aug 28.

引用本文的文献

1
Multimorbidity and Venous Thromboembolism: Epidemiological Evidence, Pathophysiology, Prophylactic and Therapeutic Anticoagulation Efficacy, Safety, and Difficulties. A Review.多重疾病与静脉血栓栓塞:流行病学证据、病理生理学、预防性和治疗性抗凝的疗效、安全性及难点。综述
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251333786. doi: 10.1177/10760296251333786. Epub 2025 Apr 15.
2
Indirect Effects of the COVID-19 Pandemic on In-Hospital Outcomes among Internal Medicine Departments: A Double-Center Retrospective Study.新冠疫情对内科住院结局的间接影响:一项双中心回顾性研究
J Clin Med. 2023 Aug 15;12(16):5304. doi: 10.3390/jcm12165304.
3

本文引用的文献

1
Venous thromboembolism prophylaxis in hospitalized elderly patients: Time to consider a 'MUST' strategy.住院老年患者静脉血栓栓塞症预防:是时候考虑“必须”策略了。
J Geriatr Cardiol. 2011 Jun;8(2):114-20. doi: 10.3724/SP.J.1263.2011.00114.
2
Venous thromboembolism prophylaxis of acutely ill hospitalized medical patients. Are we over-treating our patients?急危重症住院内科患者的静脉血栓栓塞症预防。我们是否对患者过度治疗了?
Eur J Intern Med. 2012 Apr;23(3):231-5. doi: 10.1016/j.ejim.2011.11.006. Epub 2011 Dec 16.
3
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications.
急性病住院内科患者的无症状和有症状的深静脉血栓形成:危险因素及治疗意义
Thromb J. 2022 Nov 30;20(1):72. doi: 10.1186/s12959-022-00433-8.
4
Automated versus Manual Data Extraction of the Padua Prediction Score for Venous Thromboembolism Risk in Hospitalized Older Adults.住院老年人静脉血栓栓塞风险Padua预测评分的自动与手动数据提取
Appl Clin Inform. 2018 Jul;9(3):743-751. doi: 10.1055/s-0038-1670678. Epub 2018 Sep 26.
5
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register.老年人的多药治疗:来自 REPOSI 登记处 10 年经验的教训。
Intern Emerg Med. 2018 Dec;13(8):1191-1200. doi: 10.1007/s11739-018-1941-8. Epub 2018 Aug 31.
6
Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue.内科病房静脉血栓栓塞的预防:随机评估方法问题
Intern Emerg Med. 2018 Jun;13(4):463-465. doi: 10.1007/s11739-018-1829-7. Epub 2018 Mar 14.
7
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a "real life" prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study).风险评估模型(Padua 预测评分和改善出血评分)在静脉血栓栓塞症、大出血和与药物预防 VTE 相关的卫生支出方面的临床影响:一项在单个内科病房住院患者中进行的“真实生活”前瞻性和回顾性观察研究(STIME 研究)。
Intern Emerg Med. 2018 Jun;13(4):527-534. doi: 10.1007/s11739-018-1808-z. Epub 2018 Mar 3.
8
Prophylaxis of venous thromboembolism in elderly patients with multi-morbidity: the REPOSI data.老年多病患者静脉血栓栓塞的预防:REPOSI数据
Intern Emerg Med. 2015 Mar;10(2):251-2. doi: 10.1007/s11739-014-1103-6. Epub 2014 Oct 11.
9
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI.老年人的多重疾病与多重用药:来自REPOSI的经验教训。
Intern Emerg Med. 2014 Oct;9(7):723-34. doi: 10.1007/s11739-014-1124-1. Epub 2014 Aug 28.
10
The adherence to initial processes of care in elderly patients with acute venous thromboembolism.老年急性静脉血栓栓塞症患者对初始治疗流程的依从性。
PLoS One. 2014 Jul 1;9(7):e100164. doi: 10.1371/journal.pone.0100164. eCollection 2014.
非外科患者的 VTE 预防:抗血栓治疗和血栓预防,第 9 版:美国胸科医师学会基于证据的临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e195S-e226S. doi: 10.1378/chest.11-2296.
4
Low-molecular-weight heparin and mortality in acutely ill medical patients.低分子肝素与急症医疗患者的死亡率。
N Engl J Med. 2011 Dec 29;365(26):2463-72. doi: 10.1056/NEJMoa1111288.
5
Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American College of Physicians.住院患者静脉血栓栓塞症预防:美国医师学院临床实践指南。
Ann Intern Med. 2011 Nov 1;155(9):625-32. doi: 10.7326/0003-4819-155-9-201111010-00011.
6
Comparative effectiveness research and patients with multiple chronic conditions.比较效果研究与患有多种慢性病的患者
N Engl J Med. 2011 Jun 30;364(26):2478-81. doi: 10.1056/NEJMp1100535. Epub 2011 Jun 22.
7
Predictive and associative models to identify hospitalized medical patients at risk for VTE.预测和关联模型,以识别住院医疗患者中 VTE 风险患者。
Chest. 2011 Sep;140(3):706-714. doi: 10.1378/chest.10-1944. Epub 2011 Mar 24.
8
Aging with multimorbidity: a systematic review of the literature.患有多种慢性病的老龄化:文献系统综述。
Ageing Res Rev. 2011 Sep;10(4):430-9. doi: 10.1016/j.arr.2011.03.003. Epub 2011 Mar 23.
9
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.内科病房老年患者的多种药物治疗、住院时间和住院死亡率。REPOSI 研究。
Eur J Clin Pharmacol. 2011 May;67(5):507-19. doi: 10.1007/s00228-010-0977-0. Epub 2011 Jan 11.
10
A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score.一种用于识别住院医疗患者静脉血栓栓塞风险的风险评估模型:帕多瓦预测评分。
J Thromb Haemost. 2010 Nov;8(11):2450-7. doi: 10.1111/j.1538-7836.2010.04044.x.